LabGenius, a London, UK–based synthetic biology startup, raised $3.66m in seed funding.
The round was jointly led by Kindred Capital and Acequia Capital with participation from Backed VC, Beast Ventures, Berggruen Holdings, System.One, Charlie Songhurst and angel investor Tom McInerney.
The company intends to use the funds to establish an R&D facility in Central London and mature EVA – its autonomous AI-driven evolution engine.
Led by founder and CEO Dr. James Field, LabGenius leverages AI and synthetic biology to develop new materials. The company’s foundational technology was co-developed by Field and CSO Harry Rickerby with financial backing from Innovate UK, BBSRC and SynbiCITE.
It has secured R&D contracts both from the UK Ministry of Defence (MoD) and leading multinationals.
The company is hiring.